You are here

  • Home
  • Archive
  • Volume 5, Issue 1
  • Intratumorally injected pro-inflammatory allogeneic dendritic cells as immune enhancers: a first-in-human study in unfavourable risk patients with metastatic renal cell carcinoma

Article metrics

Article menu

Download PDFPDF

Research Article
Intratumorally injected pro-inflammatory allogeneic dendritic cells as immune enhancers: a first-in-human study in unfavourable risk patients with metastatic renal cell carcinoma

 

Online download statistics by month:

Online download statistics by month: December 2019 to September 2025

AbstractFullPdf
Dec 2019330
Jan 202010101
Feb 2020771
Mar 202022223
Apr 202018183
May 202018183
Jun 202015152
Jul 202016164
Aug 2020551
Sep 202071714
Oct 202030303
Nov 202022222
Dec 202016163
Jan 202118184
Feb 202130308
Mar 202120204
Apr 202120203
May 202117178
Jun 202123232
Jul 202118182
Aug 202110102
Sep 202167655
Oct 202133335
Nov 202127286
Dec 202138383
Jan 202217194
Feb 202224247
Mar 202234347
Apr 2022313210
May 202234364
Jun 202225254
Jul 202236375
Aug 202232324
Sep 202226269
Oct 202230300
Nov 2022161816
Dec 202220202
Jan 202331315
Feb 202329291
Mar 202325261
Apr 20239102
May 202311113
Jun 202312123
Jul 202310105
Aug 202358581
Sep 2023662
Oct 202318186
Nov 202361636
Dec 20231751754
Jan 202493946
Feb 202431329
Mar 2024202015
Apr 2024222216
May 202418188
Jun 202420199
Jul 2024232410
Aug 202418175
Sep 2024202011
Oct 2024172113
Nov 202437388
Dec 202412128
Jan 2025202010
Feb 202513134
Mar 2025333320
Apr 2025404016
May 2025272714
Jun 202513134
Jul 2025110
Aug 2025110
Sep 2025220
Total18251842379